SUVICA INC
Medtech · Private
High-throughput screening (HTS) system for clonogenic assays to measure single-cell proliferation and tumor regrowth
suvica.com →- Grants
- $298K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $4.0M
- 4 awards · Health and Human S
- #141 of 4531 in medtech
- Patents
- 3
- 2 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20132014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Radiation Modulators For Head And Neck Cancer. | $249,672 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Contract Title: Radiation Modulators For Head And Neck Cancer Pop: 9/16/15 - 3/15/17 | $1,498,852 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Clonogenic High-throughput Asssay For Screening Radiation Modulators | $297,604 | |
| Federal contract | Department of Health and Human Services · Topic #366 - Phase II SBIR Contract - Clonogenic High - Throughput Assay For Screening Radiation Modulation | $1,999,989 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 138 | SILK TECHNOLOGIES, LTD. | $4.1M | $5.0M |
| 139 | Neurable Inc. | $4.1M | $12M |
| 140 | DXDISCOVERY INC | $4.1M | — |
| 141 | SUVICA INC | $4.0M | — |
| 142 | IMMUNETICS, INC. | $4.0M | $1.5M |
| 143 | SWITCHBOX INC | $4.0M | — |
| 144 | Springactive, Inc. | $3.8M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Bouvardin Derivatives And Therapeutic Uses Thereofgranted
- Bouvardin Derivatives And Therapeutic Uses Thereofgranted
- Bouvardin Derivatives And Therapeutic Uses Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.